Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Jun;42(6):788-91.
doi: 10.1136/gut.42.6.788.

Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role

J F Quinton  1 , B Sendid, D Reumaux, P Duthilleul, A Cortot, B Grandbastien, G Charrier, S R Targan, J F Colombel, D Poulain
Affiliations

Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role

J F Quinton et al. Gut. 1998 Jun.

Abstract

Background: Perinuclear antineutrophil cytoplasmic autoantibodies (pANCA) are a well recognised marker for ulcerative colitis. Antibodies to oligomannosidic epitopes of the yeast Saccharomyces cerevisiae (ASCA) are a new marker associated with Crohn's disease.

Aims: To assess the value of detecting pANCA and/or ASCA for the diagnosis of ulcerative colitis and Crohn's disease.

Methods: Serum samples were obtained from 100 patients with Crohn's disease, 101 patients with ulcerative colitis, 27 patients with other miscellaneous diarrhoeal illnesses, and 163 healthy controls. Determination of pANCA and ASCA was performed using the standardised indirect immunofluorescence technique and an ELISA, respectively.

Results: The combination of a positive pANCA test and a negative ASCA test yielded a sensitivity, specificity, and positive predictive value of 57%, 97%, and 92.5% respectively for ulcerative colitis. The combination of a positive ASCA test and a negative pANCA test yielded a sensitivity, specificity, and positive predictive value of 49%, 97%, and 96% respectively for Crohn's disease. Among patients with miscellaneous non-inflammatory bowel disorders, three were ASCA positive and two were pANCA positive. One control was ASCA positive. The presence of ASCA in patients with Crohn's disease was associated with small bowel involvement.

Conclusion: ASCA and pANCA are strongly associated with Crohn's disease and ulcerative colitis, respectively. Combination of both tests could help the diagnosis of inflammatory bowel disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
ASCA and ANCA results in the different study groups.
See this image and copyright information in PMC

Comment in

  • Surrogate markers: III.
    Sellin JH. Sellin JH. Curr Gastroenterol Rep. 2000 Oct;2(5):354. Curr Gastroenterol Rep. 2000. PMID: 12964568 No abstract available.

References

    1. Gastroenterology. 1979 Oct;77(4 Pt 2):843-6 - PubMed
    1. Br Med J. 1955 Oct 29;2(4947):1041-8 - PubMed
    1. BMJ. 1988 Oct 29;297(6656):1105-6 - PubMed
    1. APMIS Suppl. 1989;6:12-3 - PubMed
    1. J Allergy Clin Immunol. 1990 Aug;86(2):202-10 - PubMed

Publication types